Kardi Ai

A tool that, with the help of artificial intelligence, makes long-term ECG monitoring a simple, affordable process kardi.ai

Funding

• €5.3 million Series A, announced November 11, 2026. Led by Callisto Health. Valued at €23 million after the round. Česká spořitelna and Slovenská sporiteľňa (through Seed Starter), BrightCap Ventures, Purple Ventures, DEPO Ventures and Garage Angels also participated. Listed in the AI startup funding roster for November 8–14, 2026. Sources: Tech.eu, The Recursive.

Whether AI names Kardi Ai

• Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to November 14, 2026.

A company counts when an AI answer names it or cites its website. Answers vary from run to run, so each count is a dated sample.

Related records

Closest rounds in the roster for November 8–14, 2026: Biomatter ($18 million Series A, November 12, 2026), Hatz AI ($24 million Series A, November 12, 2026), Luminal ($25 million Series A, November 12, 2026), Mirendil ($1 billion Series A, November 12, 2026), Nebuly ($21 million Series A, November 12, 2026), Orakl Oncology ($34 million Series A, November 12, 2026).

Sources

• Tech.eu
• The Recursive

Every fact on this page links its source. Corrections need a public source: see Contact.